REG - Futura Medical PLC - Director/PDMR Shareholding

Futura MedicalAnnouncement

25/06/2019 16:50

RNS Number : 3971D
Futura Medical PLC
25 June 2019
 


Director/PDMR Dealings




 1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


James Barder




2


Reason for the notification




a)


Position/status


Chief Executive Officer




b)


Initial notification/Amendment


Amendment - additional disclosure to the Director Dealing announcement dated 19 November 2018 clarifying a voluntary surrender of options.  All other details were and remain correct.




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Futura Medical plc




b)


LEI


21380053QLT46UNV2303




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
 
Identification code


Ordinary Shares of 0.2 pence each
 
 
GB0033278473




b)


Nature of the transaction


Surrender of options over ordinary shares




c)


Price(s) and volume(s)
 






Price(s)


Volume(s)




61.50


250,000




 




d)


Aggregated information
-         Aggregated volume
-         Price


N/A




e)


Date of the transaction


16th November 2018




f)


Place of the transaction


Outside a trading venue




 
 
For further information please contact:
Futura Medical plc 

James Barder, Chief Executive

Angela Hildreth, Finance Director and COO

Email: Investor.relations@futuramedical.com

Tel: +44 (0) 1483 685 670
 
Liberum (Nominated Adviser and Broker)

Bidhi Bhoma

Euan Brown

Kane Collings

Tel: +44 (0) 20 3100 2000
 
For media enquiries please contact:

Optimum Strategic Communications

Mary Clark/ Hollie Vile/ Ellie Blackwell

Email: futuramedical@optimumcomms.com

Tel: +44 (0) 203 950 9144
 
Notes to editors:
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology. These products are optimised for clinical efficacy, safety, administration and patient convenience and are developed for the prescription and consumer healthcare markets as appropriate. Current therapeutic areas are sexual health, including erectile dysfunction, and pain relief. Development and commercialisation strategies are designed to maximise product differentiation and value creation whilst minimising risk.
 
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange. www.futuramedical.com
 
 
 
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFVERRIEFIA